|
How Biomarkers Are Changing Alzheimer’s Research
The past year has been filled with discussions about biomarkers and how they are a critical part of dementia research. But what exactly is a biomarker and why do they matter?
The term biomarker is short for biological marker. It is something that can be measured and evaluated to indicate something that is happening in the body. For example, biomarkers can show the response the body is having to a medication or show the presence of a disease. Simply put, biomarkers provide information about illness and health in the human body.
So where do we find biomarkers? They can be assessed in multiple ways, including in blood and spinal fluid samples, through pulse and blood pressure readings, and even test results from an MRI or CT scan.
Biomarker results help medical professionals to identify and diagnose a disease beyond symptoms only. This is especially important in Alzheimer’s disease since symptoms do not appear until decades after the disease is present, when the brain is already damaged. But early detection and diagnosis with biomarkers allow for early intervention to prevent damage.
Within MADRC, there are several studies aimed at developing new biomarkers and improving existing ones. Learn about our Research Registry and how you can get involved in advancing science by enrolling in a study here.
|